4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001193125-26-174411
Options or other derivatives
- General Counsel acquired 7,224 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Murdock Hunter R. General Counsel | 2026-04-21 | Grant or award · Performance Stock Units | +7,224 | 7,224 | D: show line 1 in the form |
Loading xslF345X06/ownership.xml…